Filter News
Area of Research
- (-) Neutron Science (8)
- (-) Nuclear Science and Technology (3)
- Biology and Environment (10)
- Clean Energy (12)
- Computational Engineering (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (2)
- Materials (7)
- Materials for Computing (2)
- National Security (6)
- Sensors and Controls (1)
- Supercomputing (22)
News Topics
- (-) Advanced Reactors (2)
- (-) Biomedical (5)
- (-) Coronavirus (5)
- (-) Frontier (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (5)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (4)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (2)
- Environment (3)
- Fusion (2)
- High-Performance Computing (1)
- Isotopes (2)
- Materials (6)
- Materials Science (14)
- Microscopy (1)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (8)
- Physics (7)
- Quantum Science (4)
- Space Exploration (3)
- Summit (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.